{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:09:49Z","timestamp":1780528189541,"version":"3.54.1"},"reference-count":14,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["No award\/grant number"],"award-info":[{"award-number":["No award\/grant number"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Stroke Vasc Neurol"],"accepted":{"date-parts":[[2020,10,2]]},"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Long-term outcomes for Medicare beneficiaries hospitalised with transient ischaemic attack (TIA) and role of ABCD<jats:sup>2<\/jats:sup> score in identifying high-risk individuals are not studied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We identified 40\u2009825 Medicare beneficiaries hospitalised from 2011 to 2014 for a TIA to a Get With The Guidelines (GWTG)-Stroke hospital and classified them using ABCD<jats:sup>2<\/jats:sup> score. Proportional hazards models were used to assess 1-year event rates of mortality and rehospitalisation (all-cause, ischaemic stroke, haemorrhagic stroke, myocardial infarction, and gastrointestinal and intracranial haemorrhage) for high-risk versus low-risk groups adjusted for patient and hospital characteristics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of the 40\u2009825 patients, 35\u2009118 (86%) were high risk (ABCD<jats:sup>2<\/jats:sup> \u22654) and 5707 (14%) were low risk (ABCD<jats:sup>2<\/jats:sup>=0\u20133). Overall rate of mortality during 1-year follow-up after hospital discharge for the index TIA was 11.7%, 44.3% were rehospitalised for any reason and 3.6% were readmitted due to stroke. Patients with ABCD<jats:sup>2<\/jats:sup> score \u22654 had higher mortality at 1 year than not (adjusted HR 1.18, 95% CI 1.07 to 1.30). Adjusted risks for ischaemic stroke, all-cause readmission and mortality\/all-cause readmission at 1 year were also significantly higher for patients with ABCD<jats:sup>2<\/jats:sup> score \u22654 vs 0\u20133. In contrast, haemorrhagic stroke, myocardial infarction, gastrointestinal bleeding and intracranial haemorrhage risk were not significantly different by ABCD<jats:sup>2<\/jats:sup> score.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study validates the use of ABCD<jats:sup>2<\/jats:sup> score for long-term risk assessment after TIA in patients aged 65 years and older. Attentive efforts for community-based follow-up care after TIA are needed for ongoing prevention in Medicare beneficiaries who were hospitalised for TIA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/svn-2020-000372","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T16:25:31Z","timestamp":1604507131000},"page":"314-318","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD<sup>2<\/sup> score"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8441-6326","authenticated-orcid":false,"given":"Shreyansh","family":"Shah","sequence":"first","affiliation":[{"name":"Department of Neurology, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Durgesh","family":"Bhandary","sequence":"additional","affiliation":[{"name":"AstraZeneca UK Ltd, Cambridge, Cambridgeshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saga","family":"Johansson","sequence":"additional","affiliation":[{"name":"AstraZeneca UK Ltd, Cambridge, Cambridgeshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric E","family":"Smith","sequence":"additional","affiliation":[{"name":"Hotchkiss Brain Institute and Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C","family":"Fonarow","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Ronald Reagan UCLA Medical Center, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naeem D","family":"Khan","sequence":"additional","affiliation":[{"name":"AstraZeneca UK Ltd, Cambridge, Cambridgeshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Peterson","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet Prvu","family":"Bettger","sequence":"additional","affiliation":[{"name":"Duke Clinical Research Institute, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"2025082410161938000_6.2.314.1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.020022"},{"key":"2025082410161938000_6.2.314.2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.553446"},{"key":"2025082410161938000_6.2.314.3","first-page":"S117","article-title":"Quality of care and ischemic stroke risk after hospitalization for transient ischemic attack: findings from get with the Guidelines-Stroke","volume":"8","author":"O'Brien","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2025082410161938000_6.2.314.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802712"},{"key":"2025082410161938000_6.2.314.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60150-0"},{"key":"2025082410161938000_6.2.314.6","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.608380"},{"key":"2025082410161938000_6.2.314.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61448-2"},{"key":"2025082410161938000_6.2.314.8","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.664060"},{"key":"2025082410161938000_6.2.314.9","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.586842"},{"key":"2025082410161938000_6.2.314.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412981"},{"key":"2025082410161938000_6.2.314.11","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.11.001","article-title":"Peterson ED and adherence evaluation of acute ischemic Stroke-Longitudinal Ar. death and rehospitalization after transient ischemic attack or acute ischemic stroke: one-year outcomes from the adherence evaluation of acute ischemic stroke-longitudinal registry","volume":"22","author":"Olson","year":"2013","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2025082410161938000_6.2.314.12","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000165926.74213.e3"},{"key":"2025082410161938000_6.2.314.13","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.571174"},{"key":"2025082410161938000_6.2.314.14","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.8.1602"}],"container-title":["Stroke and Vascular Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/svn-2020-000372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T17:16:29Z","timestamp":1756055789000},"score":1,"resource":{"primary":{"URL":"https:\/\/svn.bmj.com\/lookup\/doi\/10.1136\/svn-2020-000372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,6,28]]},"published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1136\/svn-2020-000372"],"URL":"https:\/\/doi.org\/10.1136\/svn-2020-000372","relation":{},"ISSN":["2059-8688","2059-8696"],"issn-type":[{"value":"2059-8688","type":"print"},{"value":"2059-8696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}